Resveratrol vs Pterostilbene: One Is 4x More Bioavailable — Are You Taking the Wrong One?

Published March 2026 • 4 min read

Key Takeaways

You've probably heard of resveratrol. The "red wine compound." The anti-aging darling that made David Sinclair famous. What you probably haven't heard is that there's a nearly identical molecule -- pterostilbene -- that your body actually absorbs four times better. And most people taking resveratrol are flushing money down the toilet because of it.

The Bioavailability Problem Nobody Talks About

Resveratrol sounds amazing on paper. Activates SIRT1. Mimics caloric restriction. Extended lifespan in yeast, worms, mice. The studies are compelling. The problem? Your body destroys most of it before it can do anything.

Oral bioavailability of resveratrol is roughly 20%. Your liver metabolises it almost immediately. The half-life is about 14 minutes. So that 500mg capsule you swallowed? About 100mg makes it to your bloodstream. And it's gone in under half an hour.

Pterostilbene is structurally almost identical -- same stilbene backbone, two methyl groups instead of hydroxyl groups. That tiny chemical difference changes everything. Bioavailability jumps to 80%. Half-life extends to 105 minutes. You get four times more compound reaching your cells, staying there seven times longer.

Same Target, Different Firepower

Both compounds activate SIRT1 -- the sirtuin protein linked to longevity, DNA repair, and metabolic regulation. That's the whole point. SIRT1 activation is the mechanism that made caloric restriction extend lifespan in lab animals. These compounds are supposed to give you the benefit without the starvation.

But activation strength depends on concentration at the target. If four times more pterostilbene reaches your cells and stays there seven times longer, the total SIRT1 activation is dramatically higher. It's not a subtle difference. It's an order of magnitude.

A 2012 study in Neurobiology of Aging compared the two directly. Pterostilbene outperformed resveratrol in reducing oxidative stress and improving cognitive function in aged rats. Same dose. Same duration. Better results. The pharmacokinetics explain why.

So Why Is Everyone Still Taking Resveratrol?

Marketing. Familiarity. First-mover advantage. Resveratrol got famous first. It has decades of published research. When people think "anti-aging supplement," they think resveratrol. Pterostilbene sounds like a chemistry exam answer.

There's also the research volume argument. Resveratrol has thousands of studies. Pterostilbene has hundreds. Some researchers argue you should go with the more-studied compound. That's fair. But pharmacokinetics aren't a matter of opinion. They're measurable. And they clearly favour pterostilbene.

The smart play, based on current evidence, is pterostilbene at 100-250mg daily. Some longevity researchers combine a low dose of both -- 250mg resveratrol with 100mg pterostilbene -- arguing the compounds may have synergistic effects through slightly different SIRT1 binding mechanisms. The data on that combination is thin, but the logic is sound.

The Bottom Line

If you're spending money on a sirtuin activator, you should know what your body is actually absorbing. Resveratrol has the fame. Pterostilbene has the pharmacology. And in the world of supplements, what reaches your cells is the only thing that counts.

Either way, neither compound is a magic pill. They're tools -- potentially powerful ones -- in a much larger strategy. But if you're going to take one, at least take the one your body can actually use.

Get Longevity Insights Delivered

Science-backed health tips delivered every week.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new supplement or making changes to your health regimen.